CX Institutional’s Oracle ORCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.33M | Sell |
15,908
-736
| -4% | -$133K | 0.07% | 231 |
|
|
2026
Q1 | $2.45M | Buy |
16,644
+931
| +6% | +$151K | 0.07% | 232 |
|
|
2025
Q4 | $3.06M | Sell |
15,713
-351
| -2% | -$83.6K | 0.09% | 170 |
|
|
2025
Q3 | $4.52M | Sell |
16,064
-798
| -5% | -$203K | 0.14% | 151 |
|
|
2025
Q2 | $3.69M | Buy |
16,862
+748
| +5% | +$121K | 0.13% | 155 |
|
|
2025
Q1 | $2.25M | Buy |
16,114
+737
| +5% | +$120K | 0.09% | 188 |
|
|
2024
Q4 | $2.56M | Buy |
15,377
+547
| +4% | +$97.2K | 0.1% | 161 |
|
|
2024
Q3 | $2.53M | Sell |
14,830
-22,722
| -61% | -$3.29M | 0.11% | 181 |
|
|
2024
Q2 | $5.3M | Sell |
37,552
-1,240
| -3% | -$154K | 0.25% | 102 |
|
|
2024
Q1 | $4.87M | Buy |
38,792
+24,737
| +176% | +$2.83M | 0.23% | 102 |
|
|
2023
Q4 | $1.48M | Sell |
14,055
-73
| -0.5% | -$7.97K | 0.08% | 209 |
|
|
2023
Q3 | $1.5M | Sell |
14,128
-37
| -0.3% | -$4.28K | 0.08% | 210 |
|
|
2023
Q2 | $1.69M | Sell |
14,165
-79
| -0.6% | -$8.17K | 0.09% | 227 |
|
|
2023
Q1 | $1.33M | Sell |
14,244
-36,938
| -72% | -$3.24M | 0.07% | 257 |
|
|
2022
Q4 | $4.18M | Buy |
51,182
+13,544
| +36% | +$1.03M | 0.25% | 103 |
|
|
2022
Q3 | $2.3M | Buy |
37,638
+30,131
| +401% | +$2.21M | 0.16% | 158 |
|
|
2022
Q2 | $524K | Sell |
7,507
-761
| -9% | -$55.7K | 0.04% | 329 |
|
|
2022
Q1 | $684K | Buy |
8,268
+630
| +8% | +$51K | 0.05% | 250 |
|
|
2021
Q4 | $666K | Sell |
7,638
-24,664
| -76% | -$2.32M | 0.05% | 227 |
|
|
2021
Q3 | $2.81M | Sell |
32,302
-1,042
| -3% | -$92K | 0.23% | 113 |
|
|
2021
Q2 | $2.6M | Sell |
33,344
-4,708
| -12% | -$369K | 0.21% | 113 |
|
|
2021
Q1 | $2.67M | Sell |
38,052
-48,327
| -56% | -$3.13M | 0.24% | 104 |
|
|
2020
Q4 | $5.59M | Sell |
86,379
-19,818
| -19% | -$1.18M | 0.54% | 46 |
|
|
2020
Q3 | $6.34M | Buy |
106,197
+13,746
| +15% | +$781K | 0.68% | 42 |
|
|
2020
Q2 | $5.11M | Buy |
92,451
+12,898
| +16% | +$683K | 0.67% | 34 |
|
|
2020
Q1 | $3.85M | Buy |
79,553
+53,659
| +207% | +$2.77M | 0.63% | 36 |
|
|
2019
Q4 | $1.37M | Buy |
25,894
+21,164
| +447% | +$1.17M | 0.24% | 87 |
|
|
2019
Q3 | $260K | Buy |
4,730
+31
| +0.7% | +$1.71K | 0.04% | 201 |
|
|
2019
Q2 | $268K | Buy |
4,699
+1,080
| +30% | +$58.4K | 0.04% | 201 |
|
|
2019
Q1 | $194K | Buy |
3,619
+1,945
| +116% | +$99.1K | 0.03% | 216 |
|
|
2018
Q4 | $76K | Buy |
1,674
+1,551
| +1,261% | +$74.3K | 0.02% | 224 |
|
|
2018
Q3 | $6K | Hold |
123
| – | – | ﹤0.01% | 287 |
|
|
2018
Q2 | $5K | Buy |
+123
| New | +$5.67K | ﹤0.01% | 268 |
|
Other funds holding ORCL
FWIA
CRM
UBP
CNB
II
ZIC
CX Institutional's ORCL Position: Q2 2026 in Review
CX Institutional reduced its Oracle (ORCL) stake by 4.4% in Q2 2026, selling an estimated $133K and leaving 15,908 shares worth $2.33M. The position accounts for 0.07% of the portfolio, ranked #231.
CX Institutional first reported a position in ORCL in Q2 2018 and has held it in 33 quarters since. The position peaked at $6.34M in Q3 2020. 821 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.
- CX Institutional held 15,908 shares of Oracle worth $2.33M as of Q2 2026.
- CX Institutional sold 736 Oracle shares in Q2 2026, an estimated $133K.
- Oracle made up 0.07% of CX Institutional's portfolio in Q2 2026, its #231 holding.
- CX Institutional first reported a position in Oracle in Q2 2018 and has held it in 33 quarters since.
- CX Institutional's Oracle position peaked at $6.34M in Q3 2020.
- 821 funds tracked by Wall St. Rank held Oracle as of Q2 2026.
Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.